No disease strikes more fear than cancer and none is more resistant to medical progress. This chapter illuminates the weaknesses of a health care system driven by profit rather than human need in addressing cancer. It explains how modern capitalism has undermined progress in cancer prevention and treatment. Reducing tobacco smoking has succeeded in reducing cancer, but pharmaceutical and other industries have not emphasized this approach because it is not profitable. Instead, they develop precision medicines, high intensity radiation, and private equity-financed high-tech oncology centers. While these have helped some patients, they have made cancer care exorbitantly expensive, out of reach of many Americans, and bankrupted those who can afford them. In response, cancer patients and their families, oncologists and other providers, and public officials are demanding a new approach to cancer, one that puts less emphasis on profitable drugs and devices and more on integrated prevention, early intervention, and affordable treatment approaches.